Gregory Mayes

Gregory T.
Mayes was the founder of Engage Therapeutics, Inc., founded in 2017, where the titles held included President, Chief Executive Officer & Director from 2017 to 2020.
Current jobs include President, Chief Executive Officer & Director at Antios Therapeutics, Inc. since 2020; Director at Epilepsy Foundation since 2021; Director at Receptor Life Sciences, Inc. since 2020; Member at New Jersey State Bar Association; Trustee at Kent Place School, Inc.; and Member-Health Board at City of Summit (New Jersey).
Former jobs include President, Chief Executive Officer & Director at Reunion Neuroscience, Inc. from 2022 to 2026; Independent Director at OncoSec Medical, Inc. from 2018 to 2019; Director at Advaxis, Inc. from 2016 to 2017; Independent Director at AVEO Pharmaceuticals, Inc. from 2019 to 2023; Chief Compliance Officer & VP-General Counsel at ImClone LLC from 2004 to 2010; Secretary at Unigene Laboratories, Inc. from 2012 to 2013; Executive Vice President-Human Resources at Dendreon Corp.; Senior Counsel at AstraZeneca Pharmaceuticals LP from 2001 to 2004; and Member at BioNJ, Inc. Education includes an undergraduate degree from Syracuse University conferred in 1991 and a graduate degree from Temple University Beasley School of Law.